Advertisement

Topics

Real-Life Evidence for Using a Treat-and-Extend Injection Regime for Patients with Central Retinal Vein Occlusion.

08:00 EDT 10th April 2019 | BioPortfolio

Summary of "Real-Life Evidence for Using a Treat-and-Extend Injection Regime for Patients with Central Retinal Vein Occlusion."

To report the 52-week treatment outcomes with intravitreal injections of aflibercept using a treat-and-extend regimen for treating macular edema secondary to central retinal vein occlusion (CRVO).

Affiliation

Journal Details

This article was published in the following journal.

Name: Ophthalmology and therapy
ISSN: 2193-8245
Pages:

Links

DeepDyve research library

PubMed Articles [22155 Associated PubMed Articles listed on BioPortfolio]

One-Year Results of Using a Treat-and-Extend Regimen without a Loading Phase with Anti-VEGF Agents in Patients with Treatment-Naive Diabetic Macular Edema.

To evaluate real-life outcomes in treatment-naive patients with diabetic macular edema (DME) treated with anti-vascular endothelial growth factor (VEGF) agents using a treat-and-extend regimen without...

The missing reality of real life in real-world evidence.

Reality is defined as a real event, a real thing or state of affairs. Reality exists in the places where we live our daily lives, in the relationships we have with others and in our experiences, circu...

Utility of real-world evidence for evaluating anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration.

Randomized controlled trials are the gold standard in medical research, providing evidence of the efficacy of a treatment in well-defined patient populations. By contrast, real-world studies explore t...

Randomized Trial of Treat & Extend Ranibizumab With & Without Navigated Laser versus Monthly Dosing for DME: TREX-DME 2 Year Outcomes.

To prospectively evaluate a treat & extend algorithm of ranibizumab with and without navigated laser to monthly dosing for center-involving diabetic macular edema.

Emergence of online communities: Empirical evidence and theory.

Online communities, which have become an integral part of the day-to-day life of people and organizations, exhibit much diversity in both size and activity level; some communities grow to a massive sc...

Clinical Trials [12647 Associated Clinical Trials listed on BioPortfolio]

Comparison of Safety, Effectiveness and Quality of Life Outcomes Between Labeled Versus "Treat and Extend" Regimen in Turkish Patients With Choroidal Neovascularisation Due to AMD

The purpose of the study is to compare the two treatment regimens for the patients suffering from secondary choroidal neovascularisation to the Age Related Macular Degeneration. The first ...

Observational Study to Assess Intravitreal Aflibercept Injections Used in a "Treat and Extend" Regimen in Treatment-naïve Wet Age-related Macular Degeneration Patients

The purpose of this observational study lies in the analysis of a treat-and-extend injection scheme with intravitreal aflibercept (i.e. injection into the eye), as applied in routine pract...

A Study Comparing Efficacy and Safety of "Treat-and-Extend" Regimen Versus PRN of Conbercept in AMD

The study will evaluate the efficacy and safety of two different regimens of Conbercept (Treat-and-Extend Regimen vs. PRN) in patients with wet AMD. This study is to provide long-term safe...

Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab

TREX is a phase IIIb, multicenter, randomized, controlled clinical study. Subjects will be randomized 1:2 to "monthly" (control arm) or "treat and extend" protocol (comparator arm) respect...

Comparison of VA Guided Versus OCT Guided TER Using Ranibizumab for Diabetic Macular Edema (AVOCT Study)

This study will evaluate the effectiveness of ranibizumab (Lucentis®) using two different treatment protocols in patients with vision loss from diabetic macular edema. While one group wil...

Medical and Biotech [MESH] Definitions

The use of persons coached to feign symptoms or conditions of real diseases in a life-like manner in order to teach or evaluate medical personnel.

Withholding or withdrawal of a particular treatment or treatments, often (but not necessarily) life-prolonging treatment, from a patient or from a research subject as part of a research protocol. The concept is differentiated from REFUSAL TO TREAT, where the emphasis is on the health professional's or health facility's refusal to treat a patient or group of patients when the patient or the patient's representative requests treatment. Withholding of life-prolonging treatment is usually indexed only with EUTHANASIA, PASSIVE, unless the distinction between withholding and withdrawing treatment, or the issue of withholding palliative rather than curative treatment, is discussed.

A synthetic progestin that is derived from 17-hydroxyprogesterone. It is a long-acting contraceptive that is effective both orally or by intramuscular injection and has also been used to treat breast and endometrial neoplasms.

Injection of air or a more slowly absorbed gas such as nitrogen, into the pleural space to collapse the lung. It was formerly used to treat pulmonary tuberculosis. (From Stedman, 26th ed & Dorland, 28th ed)

Differences of opinion or disagreements that may arise, for example, between health professionals and patients or their families, or against a political regime.

Advertisement
Quick Search
Advertisement
Advertisement

 


DeepDyve research library

Searches Linking to this Article